Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

<p>Abstract</p> <p>Background</p> <p>Around one third to one half of patients with hip fractures require red-cell pack transfusion. The increasing incidence of hip fracture has also raised the need for this scarce resource. Additionally, red-cell pack transfusions are n...

Full description

Bibliographic Details
Main Authors: Bernabeu-Wittel Máximo, Aparicio Reyes, Romero Manuel, Murcia-Zaragoza José, Monte-Secades Rafael, Rosso Clara, Montero Abelardo, Ruiz-Cantero Alberto, Melero-Bascones María
Format: Article
Language:English
Published: BMC 2012-02-01
Series:BMC Musculoskeletal Disorders
Subjects:
Hip fracture
Transfusion
Blood-saving strategies
Ferric carboxymaltose
Erythropoietin
Red-cell pack
Clinical trial
Online Access:http://www.biomedcentral.com/1471-2474/13/27

Internet

http://www.biomedcentral.com/1471-2474/13/27

Similar Items